Read Full Transcript     Access Interactive Transcript     Listen and Download

Key Takeaways

• Patient needs, preferences, and situations must be taken into consideration when developing clinical outcome assessments.
• Mobile health technologies contribute to the empowerment of geriatric patients, but mHealth data must be linked to meaningful clinical benefit.
• A better understanding of the barriers to diversity in clinical trials will help site staff and sponsors tailor programs to the population of interest.
• Clinical trials often don’t enroll and retain enough patients to accurately represent the real-world pool of patients who will be the drug’s primary users.

Member Benefits

• Full Video, Transcript and Audio-only Version Available

See All Insider Access Videos